Bicycle Therapeutics’ (BCYC) Buy Rating Reaffirmed at Needham & Company LLC
Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $30.00 target price on the stock. Needham & Company LLC’s price target points to a potential upside of […]
Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $30.00 target price on the stock. Needham & Company LLC’s price target points to a potential upside of […]
